EMD Serono Newsroom

To keep up with the latest news in real-time, subscribe to our email alerts, and follow us on Twitter, Facebook and LinkedIn. If you are a reporter and have questions about the company, please contact us

Latest News


Jul 31, 2018

Rockland, Massachusetts, July 31, 2018 – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced that Cheryl Schwartz joined the...

Jul 30, 2018

Cladribine tablets is an investigational oral therapy with proposed dosing of a maximum of 20 days over two years with no additional dosing required in years 3 and 4 The New Drug Application...

Jun 4, 2018

Merck KGaA, Darmstadt, Germany, today announced results from expansion cohorts of the ongoing M7824 Phase I clinical trial (NCT02517398) program at the American Society of Clinical Oncology 2018.

Jun 4, 2018

ASCO Abstract # Avelumab: 9507, 9537 Two-year follow-up data on meaningful durable responses, overall survival (OS) and progression-free survival (PFS) to be presented in patients with metastatic...

  All Press Releases